An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Choline C 11 Injection

Chemical NameCholine C 11 Injection
Dosage FormInjection (intravenous; 148 MBq to 1225 MBq)
Drug ClassRadioactive diagnostic agents
SystemMale reproductive
CompanyMayo Clinic
Approval Year2012

Indication

  • Indication for positron emission tomography (PET) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging.
Last updated on 5/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Choline C 11 Injection (choline c 11 injection) Prescribing Information2012Mayo Clinic PET Radiochemistry Facility, Rochester, MN
Document TitleYearSource
Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis. 2016Annals of Nuclear Medicine
Document TitleYearSource
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. 2021European Association of Urology
Optimum imaging strategies for advanced prostate Cancer: ASCO guideline.2020American Society of Clinical Oncology